Winner Medical Co Ltd - Asset Resilience Ratio
Winner Medical Co Ltd (300888) has an Asset Resilience Ratio of 13.59% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Winner Medical Co Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Winner Medical Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Winner Medical Co Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Winner Medical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300888 market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥2.51 Billion | 13.59% |
| Total Liquid Assets | CN¥2.51 Billion | 13.59% |
Asset Resilience Insights
- Moderate Liquidity: Winner Medical Co Ltd has 13.59% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Winner Medical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Winner Medical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for Winner Medical Co Ltd (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Winner Medical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 15.35% | CN¥2.83 Billion ≈ $413.44 Million |
CN¥18.40 Billion ≈ $2.69 Billion |
-0.53pp |
| 2024-12-31 | 15.88% | CN¥2.92 Billion ≈ $427.48 Million |
CN¥18.39 Billion ≈ $2.69 Billion |
-0.77pp |
| 2023-12-31 | 16.66% | CN¥2.85 Billion ≈ $417.05 Million |
CN¥17.11 Billion ≈ $2.50 Billion |
-7.33pp |
| 2022-12-31 | 23.99% | CN¥4.38 Billion ≈ $640.75 Million |
CN¥18.25 Billion ≈ $2.67 Billion |
+0.39pp |
| 2021-12-31 | 23.60% | CN¥3.13 Billion ≈ $458.09 Million |
CN¥13.27 Billion ≈ $1.94 Billion |
-6.99pp |
| 2020-12-31 | 30.59% | CN¥4.13 Billion ≈ $604.52 Million |
CN¥13.51 Billion ≈ $1.98 Billion |
+29.84pp |
| 2013-12-31 | 0.75% | CN¥8.53 Million ≈ $1.25 Million |
CN¥1.14 Billion ≈ $167.52 Million |
-- |
About Winner Medical Co Ltd
Winner Medical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable medical products in China and internationally. It operates in two segments, Medical Consumables and Consumer Products. The company offers wound care solutions, including gauzes, bandages, adhesive and film dressings, cotton and non-woven products, basic kits, liquid s… Read more